{"title":"主动脉瓣球囊成形术后住院结果的性别差异","authors":"Fatima Lakhani , Bertrand Ebner , Chetan Yarlagadda , Polydoros Kampaktsis , Nikolaos Spilias","doi":"10.1016/j.carrev.2025.02.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Sex differences in the prevalence and characteristics of cardiac pathologies, including aortic stenosis (AS), are well-documented. For instance, females with severe AS exhibit lower degrees of calcification but higher levels of fibrosis compared to males. This study aims to evaluate sex-based differences in in-hospital outcomes among patients with AS undergoing balloon aortic valvuloplasty (BAV).</div></div><div><h3>Methods</h3><div>National Inpatient Sample database was queried from 2015 to 2019, identifying adult patients with severe nonrheumatic AS undergoing BAV using ICD-10 codes. Statistical analyses included Chi-Squared tests for initial comparisons followed by logistic regression to adjust for covariates.</div></div><div><h3>Results</h3><div>The study included 19,510 patients: 10,556 males (54.1 %) and 8954 females (45.9 %). Females demonstrated lower rates of post-procedural in-hospital mortality, acute kidney injury, infection, ventricular arrhythmias, and pneumothorax, however higher incidence of stroke or transient ischemic attack (TIA), red blood cell transfusions, vascular complications, and pericardial effusion. Adjusted analysis revealed female patients had lower mortality rates (OR 0.89; 95 % CI [0.79–1.0]; p = 0.042), but higher rates of red blood cell transfusions (OR 1.6; 95 % CI [1.4–1.8]; p < 0.001) and vascular complications (OR 1.5; 95 % CI [1.3–1.8]; p < 0.001), without significant difference in stroke (OR 1.1; 95 % CI [0.91–1.3]; p = 0.309).</div></div><div><h3>Conclusions</h3><div>Females undergoing BAV for severe AS experienced lower in-hospital mortality but higher rates of vascular complications and red blood cell transfusions compared to males. These findings underscore the importance of a sex-specific approach in the management of AS to reduce adverse outcomes and optimize patient care.</div></div>","PeriodicalId":47657,"journal":{"name":"Cardiovascular Revascularization Medicine","volume":"81 ","pages":"Pages 111-114"},"PeriodicalIF":1.9000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sex-related differences in hospital outcomes after balloon aortic valvuloplasty\",\"authors\":\"Fatima Lakhani , Bertrand Ebner , Chetan Yarlagadda , Polydoros Kampaktsis , Nikolaos Spilias\",\"doi\":\"10.1016/j.carrev.2025.02.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Sex differences in the prevalence and characteristics of cardiac pathologies, including aortic stenosis (AS), are well-documented. For instance, females with severe AS exhibit lower degrees of calcification but higher levels of fibrosis compared to males. This study aims to evaluate sex-based differences in in-hospital outcomes among patients with AS undergoing balloon aortic valvuloplasty (BAV).</div></div><div><h3>Methods</h3><div>National Inpatient Sample database was queried from 2015 to 2019, identifying adult patients with severe nonrheumatic AS undergoing BAV using ICD-10 codes. Statistical analyses included Chi-Squared tests for initial comparisons followed by logistic regression to adjust for covariates.</div></div><div><h3>Results</h3><div>The study included 19,510 patients: 10,556 males (54.1 %) and 8954 females (45.9 %). Females demonstrated lower rates of post-procedural in-hospital mortality, acute kidney injury, infection, ventricular arrhythmias, and pneumothorax, however higher incidence of stroke or transient ischemic attack (TIA), red blood cell transfusions, vascular complications, and pericardial effusion. Adjusted analysis revealed female patients had lower mortality rates (OR 0.89; 95 % CI [0.79–1.0]; p = 0.042), but higher rates of red blood cell transfusions (OR 1.6; 95 % CI [1.4–1.8]; p < 0.001) and vascular complications (OR 1.5; 95 % CI [1.3–1.8]; p < 0.001), without significant difference in stroke (OR 1.1; 95 % CI [0.91–1.3]; p = 0.309).</div></div><div><h3>Conclusions</h3><div>Females undergoing BAV for severe AS experienced lower in-hospital mortality but higher rates of vascular complications and red blood cell transfusions compared to males. These findings underscore the importance of a sex-specific approach in the management of AS to reduce adverse outcomes and optimize patient care.</div></div>\",\"PeriodicalId\":47657,\"journal\":{\"name\":\"Cardiovascular Revascularization Medicine\",\"volume\":\"81 \",\"pages\":\"Pages 111-114\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiovascular Revascularization Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1553838925000430\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/4 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Revascularization Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1553838925000430","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/4 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
背景:包括主动脉瓣狭窄(AS)在内的心脏疾病的患病率和特征的性别差异已经得到了充分的证明。例如,与男性相比,患有严重AS的女性表现出较低程度的钙化,但较高水平的纤维化。本研究旨在评估接受球囊主动脉瓣成形术(BAV)的AS患者住院结果的性别差异。方法:查询2015 - 2019年全国住院患者样本数据库,使用ICD-10编码识别成人重症非风湿性AS BAV患者。统计分析包括对初始比较进行卡方检验,然后进行逻辑回归以调整协变量。结果:共纳入19510例患者,其中男性10556例(54.1%),女性8954例(45.9%)。女性手术后住院死亡率、急性肾损伤、感染、室性心律失常和气胸的发生率较低,但卒中或短暂性脑缺血发作(TIA)、红细胞输注、血管并发症和心包积液的发生率较高。调整后的分析显示,女性患者的死亡率较低(OR 0.89;95% ci [0.79-1.0];p = 0.042),但红细胞输注率较高(OR 1.6;95% ci [1.4 ~ 1.8];结论:与男性相比,接受BAV治疗严重AS的女性住院死亡率较低,但血管并发症和红细胞输注率较高。这些发现强调了在AS管理中采用性别特异性方法以减少不良后果和优化患者护理的重要性。
Sex-related differences in hospital outcomes after balloon aortic valvuloplasty
Background
Sex differences in the prevalence and characteristics of cardiac pathologies, including aortic stenosis (AS), are well-documented. For instance, females with severe AS exhibit lower degrees of calcification but higher levels of fibrosis compared to males. This study aims to evaluate sex-based differences in in-hospital outcomes among patients with AS undergoing balloon aortic valvuloplasty (BAV).
Methods
National Inpatient Sample database was queried from 2015 to 2019, identifying adult patients with severe nonrheumatic AS undergoing BAV using ICD-10 codes. Statistical analyses included Chi-Squared tests for initial comparisons followed by logistic regression to adjust for covariates.
Results
The study included 19,510 patients: 10,556 males (54.1 %) and 8954 females (45.9 %). Females demonstrated lower rates of post-procedural in-hospital mortality, acute kidney injury, infection, ventricular arrhythmias, and pneumothorax, however higher incidence of stroke or transient ischemic attack (TIA), red blood cell transfusions, vascular complications, and pericardial effusion. Adjusted analysis revealed female patients had lower mortality rates (OR 0.89; 95 % CI [0.79–1.0]; p = 0.042), but higher rates of red blood cell transfusions (OR 1.6; 95 % CI [1.4–1.8]; p < 0.001) and vascular complications (OR 1.5; 95 % CI [1.3–1.8]; p < 0.001), without significant difference in stroke (OR 1.1; 95 % CI [0.91–1.3]; p = 0.309).
Conclusions
Females undergoing BAV for severe AS experienced lower in-hospital mortality but higher rates of vascular complications and red blood cell transfusions compared to males. These findings underscore the importance of a sex-specific approach in the management of AS to reduce adverse outcomes and optimize patient care.
期刊介绍:
Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine. Cardiovascular Revascularization Medicine publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological interventions, restenosis management, and prevention, including experiments conducted in human subjects, in laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, etc.